2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation
Willekens G, Studt JD, Mendez A, Alberio L, Fontana P, Wuillemin WA, Schmidt A, Graf L, Gerber B, Bovet C, Sauter TC, Nagler M
Br J Haematol. 2021 May 6
doi: 10.1111/bjh.17470
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C, Korte W, Scharf RE, Pötzsch B, Greinacher A
Haemostaseologie. 2021 Apr 1
doi: 10.1055/a-1469-7481
2020
Usability of non-medicinal swabs for SARS-CoV-2 detection to circumvent supply shortages
Dollenmaier G, Würth R, Laternser E, Seiffert SN, Korte W, Nolte O
Diagnosis (Berl). 2020 Dec 21:dx-2020-0135
doi: 10.1515/dx-2020-0135
Stroke in a young adult with mild COVID-19 suggesting endotheliitis
Crippa S, Kägi G, Graf L, Meyer Sauteur PM, Kohler P
New Microbes New Infect. 2020 Oct 10:100781
doi: 10.1016/j.nmni.2020.100781
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A
Graf L, Yan S, Shen MC, Balasa V
J Med Econ. 2020 Sep 24:1
doi: 10.1080/13696998.2020.1828092
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
Korte W, Buljan M, Rösslein M, Wick P, Golubov V, Jentsch J, Reut M, Peier K, Nohynek B, Fischer A, Stolz R, Cettuzzi M, Nolte O
J Infect. 2020 Aug 24:S0163-4453(20)30567-3
doi: 10.1016/j.jinf.2020.08.032
The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count
Listyo S, Forrest E, Graf L, Korte W
J Clin Med. 2020 Jul 31;9(8):E2456
doi: 10.3390/jcm9082456
Bleeding risks for uncharacterized platelet function disorders
Brunet J, Badin M, Chong M, Iyer J, Tasneem S, Graf L, Rivard GE, Paterson AD, Pare G, Hayward CPM
Res Pract Thromb Haemost. 2020 May 30;4(5):799-806
doi: 10.1002/rth2.12374
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
Alberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin W
Swiss Med Wkly. 2020 Apr 24;150:w20210
doi: 10.4414/smw.2020.20210
Associations between self-reported sleep duration and cardiometabolic risk factors in young African-origin adults from the five-country Modeling the Epidemiologic Transition Study (METS)
Rae DE, Dugas L, Roden L, Lambert EV, Bovet P, Plange-Rhule J, Forrester T, Riesen W, Korte W, Crowley S, Reutrakul S, Luke A
Sleep Health. 2020 Apr 19:S2352-7218(20)30101-7
doi: 10.1016/j.sleh.2020.03.003
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis
Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, Hegemann I, Korte W, Kremer Hovinga J, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris D, Wuillemin W, Asmis L
Swiss Med Wkly. 2020;150:w20247
doi:10.4414/smw.2020.20247
The impact of prepartum factor XIII activity on postpartum blood loss
Haslinger C, Korte W, Hothorn T, Brun R, Greenberg C, Zimmermann R
J Thromb Haemost. 2020 Mar 16
doi: 10.1111/jth.14795
Airway Obstruction Caused by Hemorrhage: Managing a Life-Threatening Complication in Patients With Acquired Hemophilia A: A Case Report
Endermann S, Korte W, Filipovic M
A A Pract. 2020 Feb 1;14(3):83-86
doi: 10.1213/XAA.0000000000001155
2019
Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry
Spirk D, Sebastian T, Banyai M, Beer JH, Mazzolai L, Baldi T, Aujesky D, Hayoz D, Engelberger RP, Kaeslin T, Korte W, Escher R, Husmann M, Mollet A, Szucs TD, Kucher N
Semin Thromb Hemost. 2019 Nov;45(8):851-858
doi: 10.1055/s-0039-1698770
Swiss Delphi study on iron deficiency
Nowak A, Angelillo-Scherrer A, Betticher D, Dickenmann M, Guessous I, Juillerat P, Korte W, Neuner-Jehle S, Pfister O, Surbek D, Battegay E, Steurer J
Swiss Med Wkly. 2019 Jul 3;149:w20097
doi: 10.4414/smw.2019.20097
The human microbiota is associated with cardiometabolic risk across the epidemiologic transition
Fei N, Bernabé BP, Lie L, Baghdan D, Bedu-Addo K, Plange-Rhule J, Forrester TE, Lambert EV, Bovet P, Gottel N, Riesen W, Korte W, Luke A, Kliethermes SA, Layden BT, Gilbert JA, Dugas LR
PLoS One. 2019 Jul 24;14(7)
doi: 10.1371/journal.pone.0215262
First clinical case of KPC-3-producing Klebsiella michiganensis in Europe.
Seiffert SN, Wüthrich D, Gerth Y, Egli A, Kohler P, Nolte O
New Microbes New Infect. 2019 Feb 23;29:100516.
doi: 10.1016/j.nmni.2019.100516.
THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents
Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, Eberl W, Berthold F, Bergsträsser E, Gnekow A, Lassay E, Vorwerk P, Lauten M, Sauerbrey A, Rischewski J, Beilken A, Henze G, Korte W, Möricke A
Haematologica. 2019 Apr;104(4):756-765
doi: 10.3324/haematol.2018.194175
NOACs in Anesthesiology
Spahn DR, Beer JH, Borgeat A, Chassot PG, Kern C, Mach F, Nedeltchev K, Korte W
Transfus Med Hemother
doi: 10.1159/000491 400
2018
Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora
Creber C, Cooper RS, Plange-Rhule J, Bovet P, Lambert EV, Forrester TE, Schoeller D, Riesen W, Korte W, Cao G, Luke A, Dugas LR
BMC Cardiovasc Disord. 2018 Jan 10;18(1):4
doi: 10.1186/s12872-017-0737-5
Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients
Blondon M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Bounameaux H, Righini M, Nendaz M
Thromb Haemost. 2018 Jan;118(1):82-89
doi: 10.1160/TH17-06-0403
Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency
Brunet JG, Iyer JK, Badin MS, Graf L, Moffat KA, Timleck M, Spitzer E, Hayward CPM
Int J Lab Hematol. 2018 Mar 6
doi: 10.1111/ijlh.12801
Extended Half-Life Factor VIII and Factor IX Preparations
Graf L
Transfus Med Hemother 2018;45:86–91
doi: 10.1159/000488060
Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016).
Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, Kühnert M, Lier H, Maul H, Rath W, Steppat S, Surbek D, Wacker J
Geburtshilfe Frauenheilkd. 2018 Apr;78(4):382-399
doi: 10.1055/a-0582-0122
Hemotherapy with New Blood Products
Korte W, Zeerleder S.S
Transfus Med Hemother 2018;45:84
doi: 10.1159/000488379
The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody
Korte W, Graf L
Transfus Med Hemother 2018;45:92-96
doi: 10.1159/000488152
Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora
Creber C, Cooper RS, Plange-Rhule J, Bovet P, Lambert EV, Forrester TE, Schoeller D, Riesen W, Korte W, Cao G, Luke A, Dugas LR
BMC Cardiovasc Disord. 2018 Jan 10;18(1):4
doi: 10.1186/s12872-017-0737-5
Familiäre Hypercholesterinämie - Diagnose und Therapie
Schöb M, Müller P, Gerth Y, Korte W, Rickli H, Brändle M, Bärlocher A, Bilz S
Praxis 2018;107(24):1345-1353
doi: 10.1024/1661-8157/a003134
Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab
Aeppli S, Driessen C, Graf L, Hitz F
Hematol Oncol. 2018 Oct;36(4):713-714
doi: 10.1002/hon.2533
2017
Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation
Badin MS, Iyer JK, Chong M, Graf L, Rivard GE, Waye JS, Paterson AD, Pare G, Hayward CP
Haemophilia. 2017 Feb 8
doi: 10.1111/hae.13169
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit
von Rappard S, Hinnen C, Lussmann R, Rechsteiner M, Korte W
Transfus Med Hemother 2017;44:1–8
doi: 10.1159/000468946
Thrombosis in Inherited Fibrinogen Disorders
Korte W, Poon M-C, Iorio A, Makris M
Transfus Med Hemother 2017;44:1–7
doi: 10.1159/000452864
The new German guideline on postpartum haemorrhage (PPH): essential aspects for coagulation and circulatory therapy
Lier H, Schlembach D, Korte W, von Heymann C, Steppat S, Kühnert M, Maul H, Henrich W, Rath W, Wacker J, Kainer F, Surbek D, Helmer H
Anasthesiol Intensivmed Notfallmed Schmerzther. 2016 Sep;51(9):526-35
doi: 10.1055/s-0042-105937
Impact of rivaroxaban on point-of-care assays
Fontana P, Alberio L, Angelillo-Scherrer A, Asmis L, Korte W, Mednez A, Schmid P, Stricker H, Studt J, Tsakiris D, Wuillemin W, Nagler M
Thromb Res. 2017 May;153:65-70
doi: 10.1016/j.thromres.2017.03.019
Hemostasis and Hemotherapy
Korte W, Cattaneo M
Transfus Med Hemother 2017;44:68
doi: 10.1159/000471503
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk CM, Arndt V
Cancer Epidemiol. 2017 Feb;46:85-92
doi: 10.1016/j.canep. 2016.12.005
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study
Bulla O, Poncet A, Alberio L, Asmis LM, Gähler A, Graf L, Nagler M, Studt JD, Tsakiris DA, Fontana P
Haemophilia. 2017 May 24
doi: 10.1111/hae.13250
Cardiovascular risk status of Afro-origin populations across the spectrum of economic development: findings from the Modeling the Epidemiologic Transition Study
Dugas LR, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Durazo-Arvizu RA, Cao G, Cooper RS, Khatib R, Tonino L, Riesen W, Korte W, Kliethermes S, Luke A
BMC Public Health. 2017 May 12;17(1):438
doi: 10.1186/s12889-017-4318-4
In vitro and ex vivo Measurement of Prophylactic Dabigatran Concentrations with a New Ecarin-Based Thromboelastometry Test
Körber MK, Langer E, Köhr M, Wernecke KD, Korte W, von Heymann C
Transfus Med Hemother. 2017 Apr;44(2):100-105
doi: 10.1159/000470622
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels
Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M
J Thromb Haemost. 2017 Jun 2
doi: 10.1111/jth.13747
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera
Meyer SC, Steinmann E, Lehmann T, Muesser P, Passweg J, Skoda R, Tsakiris DA
Biomed Res Int. 2017;2017:9876819
doi: 10.1155/2017/9876819
The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry
Alatri A, Mazzolai L, Kucher N, Aujesky D, Beer JH, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Engelberger RP, Baumgartner I, Spirk D
Semin Thromb Hemost. 2017 Aug 4
doi: 10.1055/s-0037-1604086
Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage
Joswig H, Korte W, Früh S, Epprecht L, Hildebrandt G, Fournier JY, Stienen MN
Neurosurg Rev. 2017 Sep 10
doi: 10.1007/s10143-017-0900-6
Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review
Boehnel C, Rickli H, Graf L, Maeder MT
Catheter Cardiovasc Interv. 2017 Sep 12
doi: 10.1002/ccd.27255
Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline
Lier H, von Heymann C, Korte W, Schlembach D
Transfus Med Hemother 2017;44:1–9
doi: 10.1159/000478106
2016
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
Geyer H, Scherber R, Kosiorek H, Dueck AC, Kiladjian JJ, Xiao Z, Slot S,Zweegman S, Sackmann F, Fuentes AK, Hernández-Maraver D, Döhner K, Harrison CN, Radia D, Muxi P, Besses C, Cervantes F, Johansson PL, Andreasson B, Rambaldi A, Barbui T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L,Cahn JY, Maldonado N, Barosi G, Ferrari ML, Gale RP, Birgegard G, Xu Z, Zhang Y,Sun X, Xu J, Zhang P, te Boekhorst PA, Commandeur S, Schouten H, Pahl HL, Griesshammer M, Stegelmann F, Lehmann T, Senyak Z, Vannucchi AM, Passamonti F,Samuelsson J, Mesa RA
J Clin Oncol. 2016 Jan 10;34(2):151-9
doi: 10.1200/JCO.2015.62.9337
Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER)
Kucher N, Aujesky D, Beer JH, Mazzolai L, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Baumgartner I, Spirk D
Thromb Haemost. 2016 Aug 30;116(3):472-9
doi: 10.1160/TH16-03-0209
Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER)
Spirk D, Aujesky D, Stuck AK, Beer JH, Mazzolai L, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Robert E, Husmann M, Frauchiger B, Baumgartner I, Kucher N
Semin Thromb Hemost. 2016 Sep;42(6):642-9
doi: 10.1055/s-0036-1584131
Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder
Badin MS, Graf L, Iyer JK, Moffat KA, Seecharan JL, Hayward CP
Int J Lab Hematol. 2016 Aug 30
doi: 10.1111/ijlh.12553
The PiCT(®)test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study
Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W
J Thromb Haemost. 2016 Sep 1
doi: 10.1111/jth.13489
The social patterning of risk factors for noncommunicable diseases in five countries: evidence from the modeling the epidemiologic transition study (METS)
Stringhini S, Forrester TE, Plange-Rhule J, Lambert EV, Viswanathan B, Riesen W, Korte W, Levitt N, Tong L, Dugas LR, Shoham D, Durazo-Arvizu RA, Luke A, Bovet P
BMC Public Health. 2016 Sep 9;16(1):956
doi: 10.1186/s12889-016-3589-5
Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data
Solomon C, Korte W, Fries D, Pendrak I, Joch C, Gröner A, Birschmann I
Transfus Med Hemother. 2016 Sep;43(5):365-373
doi: 10.1159/000446813
Interview: Aktualisierung der AWMFS3- Leitlinie zur VTE-Prophylaxe
Korte W
Leading Opinions, Hämatologie & Onkologie, 2016 Feb 25
Die neue deutsche Leitlinie zur peripartalen Hämorrhagie-Wichtige Aspekte für die Gerinnungsund Kreislauftherapie
Lier H, Schlembach D, Korte W, von Heymann Ch
AINS-Anästhesiologie· Intensivmedizin· Notfallmedizin· Schmerztherapie 2016;51:526-35
Perioperatives Management der Antikoagulantien
Graf L, Korte W
Ther Umsch. 2016;73(10):545-549
doi: 10.1024/0040-5930/a000835
Peripartum Haemorrhage, Diagnosis and Therapy
Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, Kühnert M, Lier H, Maul H, Rath W, Steppat S, Surbek D, Wacker J
Geburtshilfe Frauenheilkd. 2018 Apr;78(4):382-399
doi: 10.1055/a-0582-0122
2015
Direkte orale Antikoagulantien und Medkiamenteninteraktionen
Graf L, Korte W
Therapeutische Umschau. 2015 Feb;72(2):99-104
doi: 10.1024/0040-5930/ a000650
A case of Capnocytophaga canimorsus sacral abscess in an immunocompetent patient
Joswig H, Gers B, Dollenmaier G, Heilbronner R, Strahm C
Infection. 2015 Apr;43(2):217-21
doi: 10.1007/s15010-014-0681-6
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions
Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP, Matucci Cerinic M
Thromb Haemost. 2015 Apr;113(4):686-97
doi: 10.1160/TH14-07-0625
Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE)
Spirk D, Nendaz M, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Righini M, Bounameaux H, Kucher N
Thromb Haemost. 2015 May;113(5):1127-34
doi: 10.1160/TH14-06-0525
Gallbladder perforation and massive intraabdominal haemorrhage complicating acute cholecystitis in a patient with haemophilia A
Mechera R, Graf L, Oertli D, Viehl CT
BMJ Case Rep. 2015 May 2;2015
doi: 10.1136/bcr-2014-205971
Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage
Sigle JP, Holbro A, Lehmann T, Infanti L, Gerull S, Stern M, Tichelli A,Passweg J, Buser A
Am J Clin Pathol. 2015 Jul;144(1):145-50
doi: 10.1309/AJCPN7L9RTTP NNRW
Erythropoietin receptor mutation a rush of blood to the head?
Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T
Ann Hematol. 2015 Jul;94(7):1229-31
doi: 10.1007/s00277-015-2346-7
Acute Hepatitis E Infection with coincident reactivation of EBV infection in an immunsuppressed patient with rheumatoid arthritis: a case report
Schultze D, Mani B, Dollenmeier G, Sahli R, Zbinden A,Krayenbühl PA
BMC Infect Dis. 2015 Oct 29;15:474
doi: 10.1186/s12879-015-1146-y
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells
Göckeritz E, Kerwien S, Baumann M, Wigger M, Vondey V, Neumann L, Landwehr T, Wendtner CM, Klein C, Liu N, Hallek M, Frenzel LP, Krause G
Int J Cancer. 2015 Nov 1;137(9): 2234-42
doi: 10.1002/ijc.29579
Thrombophile Faktoren und der sinnvolle Einsatz der Labordiagnostik
Graf L, Korte W
Cardiovasc 2015; Vol. 14, Nr. 2
2014
Complement factor concentrations in patients with acute myocardial infarction: time course and ability to predict left ventricular dysfunction
Brenner R, Maeder MT, Trachsel L, Ammann P, Rickli H, Korte W
Biomark Med. 2014;8(2):247-58
doi: 10.2217/bmm.13.111
Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE)
Nendaz M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Jäger K, Righini M, Bounameaux H
Thromb Haemost. 2014 Mar 3;111(3):531-8
doi: 10.1160/TH13-05-0427
Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis
Nesin V, Wiley G, Kousi M, Ong EC, Lehmann T, Nicholl DJ, Suri M, Shahrizaila N, Katsanis N, Gaffney PM, Wierenga KJ, Tsiokas L
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4197-202
doi: 10.1073/pnas. 1312520111
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC
Blood. 2014 Apr 3;123(14):2220-8
doi: 10.1182/blood-2013-11-537167
Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations
Song HK, von Heymann C, Jespersen CM, Karkouti K, Korte W, Levy JH, Ranucci M, Saugstrup T, Sellke FW
Ann Thorac Surg. 2014 May;97(5):1630-5
doi: 10.1016/j.athoracsur. 2013.12.025
Myelofibrose
Schneider T, Lehmann T
Leading Opinions- Innere Medizin. 2014;2: 56-9
Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment
Holbro A, Graf L, Topalidou M, Bucher C, Passweg JR, Tsakiris DA
Transfusion. 2014 Jun;54(6):1508-14
doi: 10.1111/trf.12511
Harmless bruises? Coagulopathy despite normal INR
Greuter L, Schöb M, Lehmann T, Diethelm M
Praxis (Bern 1994). 2014 Jul 23;103(15):899-902
doi: 10.1024/1661-8157/ a001727
Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges
Hayward CP, Moffat KA, Graf L
Int J Lab Hematol.2014 Jun;36(3):334-40
doi: 10.1111/ijlh.12220
Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin
Graf L, Moffat KA, Carlino SA, Chan AK, Iorio A, Giulivi A, Hayward CP
Int J Lab Hematol. 2014 Jun;36(3):341-51
doi: 10.1111/ijlh.12218
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
Korte W
J Blood Med. 2014 Jul 9;5:107-13
doi: 10.2147/JBM.S35395. eCollection 2014
Outcome measures in haemophilia: a systematic review
Boehlen F, Graf L, Berntorp E
Eur J Haematol Suppl. 2014 Aug;76:2-15
doi: 10.1111/ejh.12369
Massive human rivaroxaban overdose
Lehmann T, Hofer KE, Baumann M, Hasler K, Ceschi A, Kupferschmidt H, Rohde G, Korte W
Thromb Haemost. 2014 Oct;112(4):834-6
doi: 10.1160/TH14-02-0138
Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests
Vetter BN, Orlowski V, Fransen K, Niederhauser C, Aubert V, Brandenberger M, Ciardo D, Dollenmaier G, Klimkait T, Regenass S, Schmid P, Schottstedt V, Suter-Riniker F, Yerly S, Shah C, Böni J, Schüpbach J
PLoS One. 2014 Oct 24;9(10):e111552
doi: 10.1371/journal. pone.0111552
Bridging der oralen Antikoagulation
Korte W, Graf L
Der informierte Arzt. 2014;9
2013
Non-cirrhotic portal hypertension with nearly lethal consequences
Börner N, Korte W, Doenecke C, Pfister M, Meyenberger C, Semela D, Sawatzki M
Praxis (Bern 1994). 2013 May 22;102(11):681-5
doi: 10.1024/1661-8157/a001303
Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial
Bucher CM, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A
J Clin Pathol. 2013 Jan;66(1):24-8
doi: 10.1136/jclinpath-2012-201167
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report
Girsberger S, Karow A, Lundberg P, Dirnhofer S, Lehmann T, Passweg JR, Tichelli A, Skoda R, Rovó A
Acta Haematol. 2013;129(1):23-5
doi: 10.1159/000342100
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
Nagler M, Bachmann LM, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Reber G, Stricker H, Tsakiris DA, Wuillemin WA
Thromb J. 2013 Mar 7;11(1):6
doi: 10.1186/1477-9560-11-6
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors
Templeton AJ, Thürlimann B, Baumann M, Mark M, Stoll S, Schwizer M, Dietrich D, Ruhstaller T
BMC Cancer.2013 Mar 25;13:153
doi: 10.1186/1471-2407-13-153
Advancing haemostasis automation - successful implementation of robotic centrifugation and sample processing in a tertiary service hospital. Clinical chemistry and laboratory medicine
Sédille-Mostafaie N, Engler H, Lutz S, Korte W
Clin Chem Lab Med. 2013 Jun;51(6):1273-8
doi: 10.1515/cclm-2012-0625
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg JR, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter JP, Tamm M
Biol Blood Marrow Transplant. 2013 Jun;19(6):973-80
doi: 10.1016/j.bbmt. 2013.03.017
Schnellteste für A-Streptokokken und Influenza-Viren
Schultze D
Der Informierte Arzt. 2013;3
Einsatz von konventionellen NSARs und Coxiben bei Risikopatienten
Ruschitzka F, Korte W, Vavricka ST, Widler J
Hausarzt Praxis. 2013;7: 4-6
Questions et réponses sur l’utilisation du rivaroxaban (Xarelto) dans la pratique
Wuillemin WA, Alberio LA, Angelillo- Scherrer A, Huber A, Tsakiris DA, Asmis LM, Fontana P, Korte W, Mendez A, Reber G, Stricker H, Studt JD
Rev Med Suisse. 2013; 9:1375- 85
Heparininduzierte Thrombozytopenie und perioperatives Management der antithrombotischen Therapie
Tsakiris DA, Korte W, Fontana P
Schweiz Med Forum. 2013;13(36):692–95
Etodolac does not inhibit platelet aggregation
Zoller N, Gähler A, Degiacomi P, Korte W
New developments in chemistry
Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial
Karkouti K, von Heymann C, Jespersen CM, Korte W, Levy JH, Ranucci M, Sellke FW, Song HK
J Thorac Cardiovasc Surg. 2013 Oct;146(4):927-39
doi: 10.1016/j.jtcvs.2013.04.044
Peri- und intraoperative Gerinnungsstörungen und ihre Therapieempfehlungen
Korte W
Viszeralmedizin. 2013;29:303–10
doi: 10.1159/000356071
Frühes und tiefes Ansprechen sowie präzisere Identifizierung von Hochrisikopatienten mit CML
Lehmann T
Leading Opinions- Hämatologie & Onkologie. 2013; 4: 30-1
2012
Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients
Spahn DR, Korte W
Anesthesiology. 2012 Jan;116(1):9-11
doi: 10.1097/ALN. 0b013e318238c070
Rivaroxaban: Quantification by anti-Fxa assay and influence on coagulation tests: a study in 9 Swiss laboratories
Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G, Seifert B, Stricker H, Tsakiris DA, Wuillemin WA
Thromb Res. 2012 Apr;129(4):492-8
doi: 10.1016/j.thromres. 2011.06.031
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection
Schüpbach J, Bisset LR, Gebhardt MD, Regenass S, Bürgisser P, Gorgievski M, Klimkait T, Andreutti C, Martinetti G, Niederhauser C, Yerly S, Pfister S, Schultze D, Brandenberger M, Schöni-Affolter F, Scherrer AU, Günthard HF; Swiss HIV Cohort Study
BMC Infect Dis. 2012 Apr 12;12:88
doi: 10.1186/1471-2334-12-88
Long term continuous positive airway pressure (CPAP) decreases tumor necrosis factor alpha but not visceral fat in men with obstructive sleep apnea syndrome
Hegglin A, Korte W, Schoch OD, Hahn K, Hürny C, Münzer T
Sleep Medicine. 2012 Jun;16(2): 405-12
Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome
Hegglin A, Schoch OD, Korte W, Hahn K, Hürny C, Münzer T
Sleep Breath. 2012 Jun;16(2):405-12
doi: 10.1007/s11325-011-0512-2
New anticoagulants for the prevention and therapy of venous thromboembolism- a review
Sédille-Mostafaie N, Korte W
Cardiovascular Medicine. 2012;15(5):147–54
Langerhans cell histiocytosis with central nervous system involvement--complete response to 2- chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib
Baumann M, Cerny T, Sommacal A, Koeberle D
Hematol Oncol. 2012 Jun;30(2):101-4
doi: 10.1002/hon.1005
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis
Fenner L, Egger M, Bodmer T, Altpeter E, Zwahlen M, Jaton K, Pfyffer GE, Borrell S, Dubuis O, Bruderer T, Siegrist HH, Furrer H, Calmy A, Fehr J, Stalder JM, Ninet B, Böttger EC, Gagneux S; Swiss HIV Cohort Study and the Swiss Molecular Epidemiology of Tuberculosis Study Group
Antimicrob Agents Chemother. 2012 Jun;56(6):3047-53
doi: 10.1128/AAC.06460-11
First report of sandfly fever virus infection imported from Malta into Switzerland, October 2011
Schultze D, Korte W, Rafeiner P, Niedrig M
Euro Surveill. 2012 Jul 5;17(27)
Perioperative course of FXIII in children undergoing major surgery
Haas T, Korte W, Spielmann N, Mauch J, Madjdpour C, Schmugge M, Weiss M
Paediatr Anaesth. 2012 Jul;22(7):641-6
doi: 10.1111/j.1460-9592.2011.03709
Transvaginal access for NOTES: a cohort study of microbiological colonization and contamination
Linke GR, Tarantino I, Bruderer T, Celeiro J, Warschkow R, Tarr PE, Müller-Stich BP, Zerz A
Endoscopy. 2012 Jul;44(7):684-9
doi: 10.1055/s-0032-1309390
A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report
Schultze D, Müller B, Bruderer T, Dollenmaier G, Riehm JM, Boggian K
BMC Infect Dis. 2012 Oct 4;12:242
doi: 10.1186/1471-2334-12-242
Sunitinib - An Erythropoiesis Modulating Agent
Graf L, Gillessen S, Cerny T, Korte W
N ENGLJ MED 356;22 MAY31, 2007
State-of-the-Art in Hämostaseologie Teil 2
Korte W, Spannagl M
Hämostaseologie 2012;32(4):247-247
56. Jahrestagung der Gesellschaft für Thromboseund Hämostaseforschung e. V. (GTH) Joint Meeting GTH & Italian Associations of Haemostasis and Thrombosis
Korte W
Hämostaseologie 2012;32(1): 1-1
Diagnostik - Pfad "Abdominalschmerz"
Freidank H, Muser J, von Landenberg PH, von Eckardstein A, Walz B, Balmelli T, Buhl D, Korte W, Conrad W, Huber A
Forum Med Suisse. 2012;12(14–15):310–11
Thrombophilidiagnostik - Entscheidungshilfe in komplexen Risikosituationen
Baumann M, Korte W
Cardiovasc 2012; 6:4-6
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs
Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA
J Clin Oncol. 2012 Nov 20;30(33):4098-103
doi: 10.1200/JCO.2012. 42.3863
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides
Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R, Claasen J, Pallasch CP, Hallek M, Wendtner CM, Frenzel LP
Blood. 2012 Nov 8;120(19):3978-85
doi: 10.1182/blood-2012-05-431783
BCR-ABL1-negative Myeloproliferative Neoplasie
Cantoni N, Passweg JR, Lehmann T
info@onkologie 2012;3:10-14
Myeloproliferative Neoplasien, klinische Relevanz neuer Mutationen
Lehmann T, Passweg JR
info@onkologie 2012;3:15-17
Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values
Korte W, Engler H, Riesen WF, Brinkmann T
Clin Lab. 2012;58(7-8):645-57
2011
Empfehlungen für Diagnose und Behandlung der chronischen lymphatischen Leukämie in der Schweiz Teil 1: Diagnose, Staging und Prognosefaktoren Teil 2: Therapieindikationen und Therapiestrategien
Gregor M, Bargetzi M, Duchosal MA, Goede JS, Heim D, Helg C, Korte W, Leoncini L, Solenthaler M, Zenhäusern R
Schweiz Med Forum. 2011;11(6),93-7 ;11(7)118-24
Effectiveness of a new decolonisation regimen for eradication of extended-spectrum ?-lactamaseproducing Enterobacteriaceae
Buehlmann M, Bruderer T, Frei R, Widmer AF
J Hosp Infect. 2011 Feb;77(2):113-7
doi: 10.1016/j.jhin.2010.09.022
Molecular surveillance of circulating dengue genotypes through European travelers
Domingo C, Niedrig M, Gascón J, Palacios G, Reyes N, Malo MJ, Wichmann O, Ruiz J, Schultze D, Schunk M, Puente S, Vinner L, Van Esbroeck M, Schuffenecker I, Grandadam M, López-Vélez R, Tenorio A
J Travel Med. 2011 May-Jun;18(3):183-90
doi: 10.1111/j.1708-8305. 2011.00501
Peri-operative management of antiplatelet therapy in patients with coronary artery disease
Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K
Thromb Haemost. 2011 May;105(5):743-9
doi: 10.1160/TH10-04-0217
Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II
Spirk D, Ugi J, Korte W, Husmann M, Hayoz D, Baldi T, Frauchiger B, Banyai M, Aujesky D, Baumgartner I, Kucher N
Thromb Haemost. 2011 Jun;105(6):962-7
doi: 10.1160/TH11-01-0002
Periinterventionelles Management der Antikoagulation und Antiaggregation
Nagler M, Erne P, Babst R, Korte W, Wuillemin WA
Schweiz Med Forum. 2011;11(23-24):407-12
Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen
Baumann M
info@onkologie 2011;6-10
An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate
Thelwel C, Rigsby P, Longstaff C; ISTH-SSC Subcommittee on Factor XI and Contact System
J Thromb Haemost. 2011 Oct;9(10):2097-9
doi: 10.1111/j.1538-7836.2011.04455
Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers
Huober J, Baumann M, Rochlitz C, Aebi S, Güth U, von Moos R, Müller A, von Rohr L, Widmer I, Thürlimann B
Oncology. 2011;81(3-4):160-6
doi: 10.1159/000333396
Autoantibodies against inosine-5'-monophosphate dehydrogenase 2-characteristics and prevalence in patients with HCV-infection
Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M
Clin Lab. 2011;57(9-10):753-65
Diagnostische Pfade im Krankenhaus
Freidank H, Balmelli T, Buhl D, Conrad W, von Eckardstein A, Huber A, Korte W, von Landenberg PH, Muser J, Walz B
Schweiz Med Forum. 2011; 11(36): 603
Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections
Rampini SK, Bloemberg GV, Keller PM, Büchler AC, Dollenmaier G, Speck RF, Böttger EC
Clin Infect Dis. 2011 Dec;53(12):1245-51
doi: 10.1093/cid/cir692
